The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Antifungal Susceptibility Testing: Current Approaches
Open accessAbstract
Although not as ubiquitous as antibacterial susceptibility testing, antifungal susceptibility testing (AFST) is a tool of increasing importance in clinical microbiology laboratories. The goal of AFST is to reliably produce MIC values that may be used to guide patient therapy, inform epidemiological studies, and track rates of antifungal drug resistance. There are three methods that have been standardized by standards development organizations: broth dilution, disk diffusion, and azole agar screening for Aspergillus .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hussain, H. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmc076105 · Cited by 36
RetractedNational Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Self-citationEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Self-citationUllmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202 · cited 1×
“That choice may be further complicated by drug-drug interactions and/or side effects like toxicity, which are known to occur with antifungal drugs (168).”
BackgroundThe global problem of antifungal resistance: prevalence, mechanisms, and management
Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055
The antifungal pipeline: a reality check
Perfect, J. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.46 · Cited by 866
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778
Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Rodriguez-Tudela, J. L., Arendrup, M. C., Barchiesi, F., Bille, J., Chryssanthou, E., Cuenca-Estrella, M., Dannaoui, E., Denning, D. W., Donnelly, J. P., Dromer, F., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01935.x · Cited by 652
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
Verweij, P. E., Snelders, E., Kema, G. H., Mellado, E., & Melchers, W. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70265-8 · Cited by 604
Verweij, P. E., Chowdhary, A., Melchers, W. J. G., & Meis, J. F. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ885 · Cited by 561
Changes in the epidemiological landscape of invasive candidiasis
Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547
Self-citationFluconazole resistance in Candida species: a current perspective
Berkow, E., & Lockhart, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s118892 · Cited by 542
Self-citationKathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F., & Chowdhary, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00367-15 · Cited by 532
Resistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512
Incidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
Mylonakis, E., Clancy, C. J., Ostrosky-Zeichner, L., Garey, K. W., Alangaden, G. J., Vazquez, J. A., Groeger, J. S., Judson, M. A., Vinagre, Y.-M., Heard, S. O., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu959 · Cited by 443
Self-citationPark, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434
Method for antifungal disk diffusion susceptibility testing of yeasts : Approved guideline
Rex, J. H., & Clinical (2009) · Clinical and Laboratory Standards Institute eBooks · Cited by 422
ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.
Cuenca-Estrella, M., Verweij, P. E., Arendrup, M. C., Arikan-Akdagli, S., Bille, J., Donnelly, J. P., Jensen, H. E., Lass-Flörl, C., Richardson, M. D., Akova, M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12038 · Cited by 386
Chowdhary, A., Kathuria, S., Xu, J., & Meis, J. F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003633 · Cited by 380
Multiple-Triazole–Resistant Aspergillosis
Verweij, P. E., Mellado, E., & Melchers, W. J. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmc061720 · Cited by 380
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Self-citationEagle, H., & Musselman, A. D. (1948) · Journal of Experimental Medicine · doi:10.1084/jem.88.1.99 · Cited by 375
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw444 · Cited by 373
Has antifungal susceptibility testing come of age
Rex, J. H., & Pfaller, M. A. (2002) · Clinical Infectious Diseases · doi:10.1086/342384 · Cited by 361
Douglas, C. M., D'Ippolito, J. A., Shei, G. J., Meinz, M., Onishi, J., Marrinan, J. A., Li, W., Abruzzo, G. K., Flattery, A., Bartizal, K., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2471 · Cited by 344
Pfaller, M. A., Diekema, D. J., Andes, D., Arendrup, M. C., Brown, S. D., Lockhart, S. R., Motyl, M., & Perlin, D. S. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.004 · Cited by 334
Self-citationPfaller, M. A., Andes, D., Diekema, D. J., Espinel-Ingroff, A., & Sheehan, D. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.09.002 · Cited by 314
Denning, D. W., Park, S., Lass-Florl, C., Fraczek, M. G., Kirwan, M., Gore, R., Smith, J., Bueid, A., Moore, C. B., Bowyer, P., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir179 · Cited by 313
Lestrade, P. P., Bentvelsen, R. G., Schauwvlieghe, A. F. A. D., Schalekamp, S., van der Velden, W. J. F. M., Kuiper, E. J., van Paassen, J., van der Hoven, B., van der Lee, H. A., Melchers, W. J. G., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy859 · Cited by 310
Lockhart, S. R., Iqbal, N., Cleveland, A. A., Farley, M. M., Harrison, L. H., Bolden, C. B., Baughman, W., Stein, B., Hollick, R., Park, B. J., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01283-12 · Cited by 299
Self-citationIngham, C. J., Sprenkels, A., Bomer, J., Molenaar, D., van den Berg, A., van Hylckama Vlieg, J. E. T., & de Vos, W. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701693104 · Cited by 280
Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment
Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix210 · Cited by 262
Lockhart, S. R., Frade, J. P., Etienne, K. A., Pfaller, M. A., Diekema, D. J., & Balajee, S. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-11 · Cited by 231
Self-citationBalashov, S. V., Park, S., & Perlin, D. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-05 · Cited by 225
Stevens, D. A., Espiritu, M., & Parmar, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3407-3411.2004 · Cited by 217
Espinel-Ingroff, A., Arendrup, M. C., Pfaller, M. A., Bonfietti, L. X., Bustamante, B., Canton, E., Chryssanthou, E., Cuenca-Estrella, M., Dannaoui, E., Fothergill, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01519-13 · Cited by 216 · cited 1×
“It should be noted that although the CLSI has developed breakpoints for caspofungin against several species of yeast, problems have been noted with testing of caspofungin (31, 32).”
BackgroundSelf-citationWanger, A., Mills, K., Nelson, P. W., & Rex, J. H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2520 · Cited by 202
Stevens, D. A., Ichinomiya, M., Koshi, Y., & Horiuchi, H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00563-06 · Cited by 193 · cited 1×
“A decrease in cell wall proteins -1,3-glucan and -1,6-glucan and an increase in cell wall chitin content are the most frequently indicated sources of the regrowth (153).”
BackgroundVallabhaneni, S., Cleveland, A. A., Farley, M. M., Harrison, L. H., Schaffner, W., Beldavs, Z. G., Derado, G., Pham, C. D., Lockhart, S. R., & Smith, R. M. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv163 · Cited by 187
Self-citationPfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., & Hollis, R. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.4.1440-1446.2003 · Cited by 185
Espinel-Ingroff, A., Arthington-Skaggs, B., Iqbal, N., Ellis, D., Pfaller, M. A., Messer, S., Rinaldi, M., Fothergill, A., Gibbs, D. L., & Wang, A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00134-07 · Cited by 182
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Gonçalves, S. S., Souza, A. C. R., Chowdhary, A., Meis, J. F., & Colombo, A. L. (2016) · Mycoses · doi:10.1111/myc.12469 · Cited by 180
Odds, F. C., Motyl, M., Andrade, R., Bille, J., Cantón, E., Cuenca-Estrella, M., Davidson, A., Durussel, C., Ellis, D., Foraker, E., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3475-3482.2004 · Cited by 173
Self-citationCuenca-Estrella, M., Gomez-Lopez, A., Alastruey-Izquierdo, A., Bernal-Martinez, L., Cuesta, I., Buitrago, M. J., & Rodriguez-Tudela, J. L. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02316-09 · Cited by 173
Chamilos, G., Lewis, R. E., Albert, N., & Kontoyiannis, D. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00095-07 · Cited by 171
Shields, R. K., Nguyen, M. H., Press, E. G., Kwa, A. L., Cheng, S., Du, C., & Clancy, C. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00027-12 · Cited by 171
Changing epidemiology of candidaemia in Australia
Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw422 · Cited by 163
Marinach, C., Alanio, A., Palous, M., Kwasek, S., Fekkar, A., Brossas, J., Brun, S., Snounou, G., Hennequin, C., Sanglard, D., et al. (2009) · PROTEOMICS · doi:10.1002/pmic.200900152 · Cited by 159
Arthington-Skaggs, B. A., Lee-Yang, W., Ciblak, M. A., Frade, J. P., Brandt, M. E., Hajjeh, R. A., Harrison, L. H., Sofair, A. N., & Warnock, A. D. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2477-2481.2002 · Cited by 158
Chong, G. M., van de Sande, W. W. J., Dingemans, G., Gaajetaan, G. R., Vonk, A. G., Hayette, M., van Tegelen, D. W. E., Simons, G., & Rijnders, B. J. A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03216-14 · Cited by 154
Galgiani, J. N., & Stevens, D. A. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.10.4.721 · Cited by 150
Triazole resistance surveillance in Aspergillus fumigatus
Resendiz Sharpe, A., Lagrou, K., Meis, J. F., Chowdhary, A., Lockhart, S. R., Verweij, P. E., & on behalf of the ISHAM/ECMM Aspergillus Resistance Surveillance working group (2018) · Medical Mycology · doi:10.1093/mmy/myx144 · Cited by 150
Self-citationChanging epidemiology of candidaemia in Australia
Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx047 · Cited by 149
Alexander, B. D., Byrne, T. C., Smith, K. L., Hanson, K. E., Anstrom, K. J., Perfect, J. R., & Reller, L. B. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01840-06 · Cited by 148
The Trailing End Point Phenotype in Antifungal Susceptibility Testing Is pH Dependent
Marr, K. A., Rustad, T. R., Rex, J. H., & White, T. C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1383 · Cited by 145
Arendrup, M. C., Meletiadis, J., Mouton, J. W., Guinea, J., Cuenca‐Estrella, M., Lagrou, K., Howard, S. J., Arendrup, M. C., Meletiadis, J., Howard, S. J., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.017 · Cited by 145
Arthington-Skaggs, B. A., Warnock, D. W., & Morrison, C. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2081-2085.2000 · Cited by 142
Carolis, E. D., Vella, A., Florio, A. R., Posteraro, P., Perlin, D. S., Sanguinetti, M., & Posteraro, B. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00224-12 · Cited by 142
Pfaller, M. A., Diekema, D. J., Procop, G. W., & Rinaldi, M. G. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00403-07 · Cited by 140
Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region
Tan, T. Y., Hsu, L. Y., Alejandria, M. M., Chaiwarith, R., Chinniah, T., Chayakulkeeree, M., Choudhury, S., Chen, Y. H., Shin, J. H., Kiratisin, P., et al. (2016) · Medical Mycology · doi:10.1093/mmy/myv114 · Cited by 139
Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania
Chowdhary, A., Sharma, C., van den Boom, M., Yntema, J. B., Hagen, F., Verweij, P. E., & Meis, J. F. G. M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku259 · Cited by 137
Orasch, C., Marchetti, O., Garbino, J., Schrenzel, J., Zimmerli, S., Mühlethaler, K., Pfyffer, G. E., Ruef, C., Fehr, J. S., Zbinden, R., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12440 · Cited by 134
Espinel‐Ingroff, A., Pfaller, M. A., Messer, S. A., Knapp, C. C., Killian, S. B., Norris, H. A., & Ghannoum, M. A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.3.591-595.1999 · Cited by 134
Revankar, S. G., Kirkpatrick, W. R., McAtee, R. K., Fothergill, A. W., Redding, S. W., Rinaldi, M. G., & Patterson, T. F. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.153-156.1998 · Cited by 133
Wallet, F., Nseir, S., Baumann, L., Herwegh, S., Sendid, B., Boulo, M., Roussel‐Delvallez, M., Durocher, A.-M., & Courcol, R. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02940.x · Cited by 133
Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals
Pina‐Vaz, C., Sansonetty, F., Rodrigues, A. G., Costa‐Oliveira, S., Tavares, C., & Martinez‐de‐Oliveira, J. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1198-743x.2001.00307.x · Cited by 130
Pfaller, M. A., Castanheira, M., Diekema, D. J., Messer, S. A., Moet, G. J., & Jones, R. N. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02445-09 · Cited by 130
Pfaller, M. A., Andes, D., Arendrup, M. C., Diekema, D. J., Espinel-Ingroff, A., Alexander, B. D., Brown, S. D., Chaturvedi, V., Fowler, C. L., Ghannoum, M. A., et al. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.03.002 · Cited by 130
Self-citationEUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole
Arendrup, M. C., Cuenca‐Estrella, M., Lass‐Flörl, C., & Hope, W. W. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03890.x · Cited by 129
Vella, A., De Carolis, E., Vaccaro, L., Posteraro, P., Perlin, D. S., Kostrzewa, M., Posteraro, B., & Sanguinetti, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00903-13 · Cited by 124
Rodriguez-Tudela, J. L., Jp, D., Arendrup, M., Arıkan, S., Barchiesi, F., Billé, J., Chryssanthou, E., Cuenca‐Estrella, M., Dannaoui, É., Denning, D. W., et al. (2009) · Research Explorer (The University of Manchester) · Cited by 122
Chowdhary, A., Sharma, C., Kathuria, S., Hagen, F., & Meis, J. F. G. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00428 · Cited by 121
Castanheira, M., Deshpande, L. M., Davis, A. P., Rhomberg, P. R., & Pfaller, M. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-17 · Cited by 119
Barry, A. L., Pfaller, M. A., Rennie, R. P., FUCHS, P. C., & Brown, S. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1781-1784.2002 · Cited by 114
Pfaller, M. A., Messer, S. A., Mills, K., & Bolmström, A. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3359-3361.2000 · Cited by 109
Pfaller, M. A., Messer, S. A., & Coffman, S. L. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.5.1094-1097.1995 · Cited by 108
Lozano‐Chiu, M., Paetznick, V. L., Ghannoum, M. A., & Rex, J. H. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2817-2822.1998 · Cited by 107
Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00136-13 · Cited by 105
Galgiani, J. N., Reiser, J., Brass, C., Espinel-Ingroff, A. V., Gordon, M. A., & Kerkering, T. M. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.9.1343 · Cited by 104
Environmental Isolates of Azole-Resistant Aspergillus fumigatus in Germany
Bader, O., Tünnermann, J., Dudakova, A., Tangwattanachuleeporn, M., Weig, M., & Groß, U. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00100-15 · Cited by 103
Studies of the paradoxical effect of caspofungin at high drug concentrations
Stevens, D. A., White, T. C., Perlin, D. S., & Selitrennikoff, C. P. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.10.006 · Cited by 103
Twenty-two years of candidaemia surveillance: results from a Norwegian national study
Hesstvedt, L., Gaustad, P., Andersen, C. T., Haarr, E., Hannula, R., Haukland, H. H., Hermansen, N. O., Larssen, K. W., Mylvaganam, H., Ranheim, T. E., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.008 · Cited by 101
Espinel‐Ingroff, A., & Rezusta, A. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.2101-2107.2002 · Cited by 101
Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection
Lepak, A. J., Zhao, M., Berkow, E. L., Lockhart, S. R., & Andes, D. R. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00791-17 · Cited by 100
Self-citationEvaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin B
Pfaller, M. A., Messer, S. A., & Bolmström, A. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00120-5 · Cited by 99
Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis
Clemons, K. V., Espiritu, M., Parmar, R., & Stevens, D. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1293-1297.2006 · Cited by 99
Multi‐triazole‐resistant Aspergillus fumigatus infections in Australia
Kidd, S. E., Goeman, E., Meis, J. F. G. M., Slavin, M. A., & Verweij, P. E. (2015) · Mycoses · doi:10.1111/myc.12324 · Cited by 97
Nationwide Surveillance of Azole Resistance in Aspergillus Diseases
Vermeulen, E., Maertens, J. A., Bel, A. D., Nulens, E., Boelens, J., Surmont, I., Mertens, A., Boel, A., & Lagrou, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00233-15 · Cited by 96
Espinel‐Ingroff, A., Pfaller, M. A., Messer, S. A., Knapp, C. C., Holliday, N. M., & Killian, S. B. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.718-721.2004 · Cited by 94
Guinea, J., Verweij, P. E., Meletiadis, J., Mouton, J. W., Barchiesi, F., Arendrup, M. C., Arendrup, M. C., Arıkan-Akdağlı, S., Barchiesi, F., Castanheira, M., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.09.008 · Cited by 93
Ramani, R., & Chaturvedi, V. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2752-2758.2000 · Cited by 90
Pfaller, M. A., Boyken, L. B., Messer, S. A., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5208-5213.2005 · Cited by 90
A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion
Meis, J. F. G. M., Petrou, M. A., Billé, J., Ellis, D., & Gibbs, D. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00152-2 · Cited by 88
Improved Detection of Amphotericin B-Resistant Isolates of Candida lusitaniae by Etest
Peyron, F., Favel, A., Michel-Nguyen, A., Gilly, M., Regli, P., & Bolmström, A. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.339-342.2001 · Cited by 87
Fluconazole Disk Diffusion Susceptibility Testing of Candida Species
Kirkpatrick, W. R., Turner, T. M., Fothergill, A. W., McCarthy, D. I., Redding, S. W., Rinaldi, M. G., & Patterson, T. F. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.11.3429-3432.1998 · Cited by 82
Pfaller, J. B., Messer, S. A., Hollis, R. J., Diekema, D. J., & Pfaller, M. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.3.1126-1129.2003 · Cited by 82
Lockhart, S. R., Ghannoum, M. A., & Alexander, B. D. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02416-16 · Cited by 81 · cited 1×
“it is probable that it has developed resistance (167).”
BackgroundSelf-citationEpidemiology and reporting of candidaemia in Belgium: a multi-centre study
Trouvé, C., Blot, S. I., Hayette, M., Jonckheere, S., Patteet, S., Rodriguez‐Villalobos, H., Symoens, F., Wijngaerden, E. V., & Lagrou, K. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2841-3 · Cited by 81
Calhoun, D. L., Roberts, G. D., Galgiani, J. N., Bennett, J. E., Feingold, D. S., Jorgensen, J., Kobayashi, G. S., & Shadomy, S. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.23.2.298-301.1986 · Cited by 80
EUCAST Technical Note on Voriconazole and Aspergillus spp.
Hope, W. W., Cuenca‐Estrella, M., Lass‐Flörl, C., & Arendrup, M. C. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12148 · Cited by 80
Fleischhacker, M., Radecke, C., Schulz, B., & Ruhnke, M. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0411-4 · Cited by 78
Pfaller, M. A., Chaturvedi, V. P., Diekema, D. J., Ghannoum, M. A., Holliday, N. M., Killian, S. B., Knapp, C. C., Messer, S. A., Miskou, A., & Ramani, R. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.05.008 · Cited by 76
Pfaller, M. A., Messer, S. A., Diekema, D. J., Jones, R. N., & Castanheira, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02481-13 · Cited by 74 · cited 1×
“These problems are not encountered when testing with anidulafungin or micafungin, which can be used as surrogates for caspofungin resistance (33, 34).”
BackgroundMorace, G., Amato, G., Bistoni, F., Fadda, G., Marone, P., Montagna, M. T., Oliveri, S. M., Polonelli, L., Rigoli, R., Mancuso, I., et al. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.8.2953-2958.2002 · Cited by 74
Lavergne, R., Morio, F., Favennec, L., Dominique, S., Meis, J. F. G. M., Gargala, G., Verweij, P. E., & Pape, P. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00127-15 · Cited by 74
Martín‐Mazuelos, E., Pemán, J., Valverde, A., Chaves, M., Serrano, M. C., & Cantón, E. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg384 · Cited by 72
Dannaoui, É., Gabriel, F., Gaboyard, M., Lagardere, G., Audebert, L., Quesne, G., Godichaud, S., Verweij, P. E., Accoceberry, I., & Bougnoux, M. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01032-17 · Cited by 70
Rapid susceptibility testing of fungi by flow cytometry using vital staining
Wenisch, C., Linnau, K. F., Parschalk, B., Zedtwitz‐Liebenstein, K., & Georgopoulos, A. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.5-10.1997 · Cited by 69
Pfaller, M. A., Chaturvedi, V. P., Diekema, D. J., Ghannoum, M. A., Holliday, N. M., Killian, S. B., Knapp, C. C., Messer, S. A., Miskov, A., & Ramani, R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00493-08 · Cited by 68
Vatanshenassan, M., Boekhout, T., Lass‐Flörl, C., Lackner, M., Schubert, S., Kostrzewa, M., & Sparbier, K. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00420-18 · Cited by 68
Cuenca‐Estrella, M., Gómez‐López, A., Mellado, E., & Rodriguez-Tudela, J. L. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01166.x · Cited by 66
Torres-Narbona, M., Guinea, J., Martínez-Alarcón, J., Peláez, T., & Bouza, E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01539-06 · Cited by 66
Saraçlı, M. A., Fothergill, A. W., Sutton, D. A., & Wiederhold, N. P. (2015) · Medical Mycology · doi:10.1093/mmy/myv046 · Cited by 65
Maiolo, E. M., Tafin, U. F., Borens, O., & Trampuž, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00057-14 · Cited by 64
Vella, A., Carolis, E. D., Mello, E., Perlin, D. S., Sanglard, D., Sanguinetti, M., & Posteraro, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-09329-4 · Cited by 64
Pfaller, M. A., Messer, S. A., Mills, K., Bolmström, A., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.12.4387-4389.2001 · Cited by 63
Ingham, C. J., Boonstra, S., Levels, S., de Lange, M., Meis, J. F. G. M., & Schneeberger, P. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033818 · Cited by 63
Buil, J. B., van der Lee, H. A. L., Rijs, A. J. M. M., Zoll, J., Hovestadt, J. A. M. F., Melchers, W. J. G., & Verweij, P. E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01250-17 · Cited by 63
Arendrup, M. C., Kahlmeter, G., Rodrı́guez-Tudela, J. L., & Donnelly, J. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01624-08 · Cited by 62
Galgiani, J. N., & Stevens, D. A. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.13.2.249 · Cited by 62
Rapid Detection of FKS -Associated Echinocandin Resistance in Candida glabrata
Zhao, Y., Nagasaki, Y., Kordalewska, M., Press, E. G., Shields, R. K., Nguyen, M. H., Clancy, C. J., & Perlin, D. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-16 · Cited by 61
Arendrup, M. C., Verweij, P. E., Mouton, J. W., Lagrou, K., & Meletiadis, J. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx319 · Cited by 61
Rapid Diagnosis of Azole-Resistant Aspergillosis by Direct PCR Using Tissue Specimens
van der Linden, J. W. M., Snelders, E., Arends, J. P., Daenen, S. M. G. J., Melchers, W. J. G., & Verweij, P. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02221-09 · Cited by 60
Pfaller, M. A., Bale, M. J., Buschelman, B. J., Lancaster, M., Espinel-Ingroff, A. V., Rex, J. H., & Rinaldi, M. G. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.7.1650-1653.1994 · Cited by 59
Pham, C. D., Bolden, C. B., Kuykendall, R. J., & Lockhart, S. R. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03378-13 · Cited by 58
Self-citationPfaller, M. A., Messer, S. A., Bolmström, A., Odds, F. C., & Rex, J. H. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.7.1691-1693.1996 · Cited by 58
Changing epidemiology of candidemia in a medical center in middle Taiwan
Hii, I.-M., Chang, H.-L., Lin, L.-C., Lee, Y.-L., Liu, Y.-M., Liu, C.-E., Chen, C.-H., Cheng, Y.-R., & Chang, C.-Y. (2015) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2013.08.017 · Cited by 56
Alvarado-Ramírez, E., & Torres-Rodríguez, J. M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01176-06 · Cited by 55
Klotz, U., Schmidt, D., Willinger, B., Steinmann, E., Buer, J., Rath, P., & Steinmann, J. (2016) · Mycoses · doi:10.1111/myc.12472 · Cited by 55
Multiple Fungicide-Driven Alterations in Azole-ResistantAspergillus fumigatus, Colombia, 2015
Pape, P. L., Lavergne, R., Morio, F., & Álvarez, C. (2015) · Emerging infectious diseases · doi:10.3201/eid2201.150978 · Cited by 55
Pfaller, M. A., Hazen, K. C., Messer, S. A., Boyken, L. B., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3607-3612.2004 · Cited by 55
Lamoth, F., & Alexander, B. D. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00925-15 · Cited by 53
Pfaller, M. A., Messer, S. A., Houston, A. K., Mills, K., Bolmström, A., & Jones, R. N. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3715-3717.2000 · Cited by 53
Zhao, Y., Stensvold, C. R., Perlin, D. S., & Arendrup, M. C. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt071 · Cited by 52
Bourgeois, N., Dehandschoewercker, L., Bertout, S., Bousquet, P., Rispail, P., & Lachaud, L. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01096-09 · Cited by 51
Pfaller, M. A., Diekema, D. J., Jones, R. N., & Castanheira, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00782-14 · Cited by 51
Posteraro, B., Martucci, R., Sorda, M. L., Fiori, B., Sanglard, D., Carolis, E. D., Florio, A. R., Fadda, G., & Sanguinetti, M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02070-08 · Cited by 50
EUCAST technical note on Amphotericin B
Lass-Flörl, C., Arendrup, M. C., Rodriguez-Tudela, J.-L., Cuenca-Estrella, M., Donnelly, P., & Hope, W. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03644.x · Cited by 49
Echinocandin Resistance in Candida Species: a Review of Recent Developments
Wiederhold, N. P. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0549-2 · Cited by 48
Molecular Detection of Azole-Resistant Aspergillus fumigatus in Clinical Samples
Buil, J. B., Zoll, J., Verweij, P. E., & Melchers, W. J. G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00515 · Cited by 48
Castro, C., Serrano, M. C. L., Flores, B., Espinel‐Ingroff, A., & Martín‐Mazuelos, E. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.9.4358-4360.2004 · Cited by 47
Chaturvedi, V. P., Ramani, R., & Pfaller, M. A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2249-2251.2004 · Cited by 45
Wang, H., Hsieh, M., Choi, P., & Wu, C. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00780-18 · Cited by 45
Amphotericin B resistance testing of Candida spp.: a comparison of methods
Law, D., Moore, C. B., & Denning, D. W. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.109 · Cited by 44
EUCAST Technical Note on Candida and micafungin, anidulafungin and fluconazole
Cavling Arendrup, M., Cuenca‐Estrella, M., Lass‐Flörl, C., Hope, W. W., & The European Committee on Antimicrobial Susceptibility Testing – Subcommittee on Antifungal Susceptibility Testing (EUCAST‐AFST) (2014) · Mycoses · doi:10.1111/myc.12170 · Cited by 43
Astvad, K. M., Perlin, D. S., Johansen, H. K., Jensen, R. H., & Arendrup, M. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01382-12 · Cited by 43
Ingham, C. J., & Schneeberger, P. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035478 · Cited by 42
Méndez, C. C., Serrano, M. D. C., Valverde, A., Pemán, J., Almeida, C., & Martín‐Mazuelos, E. (2008) · Medical Mycology · doi:10.1080/13693780701670491 · Cited by 42
Montesinos, I., Argudín, M. Á., Hites, M., Ahajjam, F., Dodémont, M., DAGYARAN, C., Bakkali, M., Etienne, I., Jacobs, F., Knoop, C., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00520-17 · Cited by 42
Arendrup, M. C., Lundgren, B., Jensen, I., Hansen, B. S., & Frimodt-Møller, N. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.521 · Cited by 41
Diagnosis and management of aspergillosis in the Netherlands: a national survey
Lestrade, P. P. A., Meis, J. F. G. M., Arends, J. P., van der Beek, M. T., Brauwer, E. D., van Dijk, K., de Greeff, S. C., Haas, P., Hodiamont, C. J., Kuijper, E. J., et al. (2015) · Mycoses · doi:10.1111/myc.12440 · Cited by 41
Pfaller, M. A., Diekema, D. J., Procop, G. W., & Rinaldi, M. G. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.05.019 · Cited by 40
Pfaller, M. A., Messer, S. A., Mills, K., Bolmström, A., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.11.3952-3954.2001 · Cited by 39
Pfaller, M. A., Messer, S. A., Boyken, L. B., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.380-383.2004 · Cited by 39
Peterson, J. F., Pfaller, M. A., Diekema, D. J., Rinaldi, M. G., Riebe, K. M., & Ledeboer, N. A. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02517-10 · Cited by 39
Entenza, J. M., Bétrisey, B., Manuel, O., Giddey, M., Sakwińska, O., Laurent, F. J., & Bizzini, A. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01820-13 · Cited by 38
Disk Agar Diffusion Susceptibility Testing of Yeasts
Saubolle, M. A., & Hoeprich, P. D. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.4.517 · Cited by 37
Antifungal Susceptibility Testing of Fluconazole by Flow Cytometry Correlates with Clinical Outcome
Wenisch, C., Moore, C. B., Krause, R., Presterl, E., Pichňa, P., & Denning, D. W. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2458-2462.2001 · Cited by 36
Mass spectrometry applications in microbiology beyond microbe identification: progress and potential
Sanguinetti, M., & Posteraro, B. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1231578 · Cited by 36
EUCAST technical note on posaconazole
Arendrup, M. C., Cuenca-Estrella, M., Donnelly, J. P., Hope, W., Lass-Flörl, C., & Rodriguez-Tudela, J.-L. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03646.x · Cited by 34
Guinea, J., Peláez, T., Alcalá, L., & Bouza, E. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.03.004 · Cited by 33
Diekema, D. J., Messer, S. A., Hollis, R. J., Boyken, L. B., Tendolkar, S., Kroeger, J. S., & Pfaller, M. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02087-06 · Cited by 33
Peyron, F., Favel, A., Guiraud-Dauriac, H., Mzibri, M. E., Chastin, C., Duménil, G., & Regli, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1537 · Cited by 33
Pfaller, M. A., Messer, S. A., Hollis, R. J., Espinel‐Ingroff, A., Ghannoum, M. A., Plavan, H., Killian, S. B., & Knapp, C. C. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00026-1 · Cited by 32
CHROMagar Candida Medium for Direct Susceptibility Testing of Yeast from Blood Cultures
Tan, G. L., & Peterson, E. M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1727-1731.2005 · Cited by 32
Rapid flow-cytometric susceptibility testing of Candida species
Rudensky, B., Broidie, E., Yinnon, A. M., Weitzman, T., Paz, E., Keller, N., & Raveh, D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh492 · Cited by 31
Brown, S. D., & Traczewski, M. M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01732-06 · Cited by 31
Schauwvlieghe, A. F. A. D., de Jonge, N., van Dijk, K., Verweij, P. E., Brüggemann, R. J. M., Biemond, B. J., Bart, A., Borne, P. A. V. D., Verbon, A., van der Beek, M. T., et al. (2018) · Mycoses · doi:10.1111/myc.12788 · Cited by 31
Patel, R. J., Mendrick, C. A., Knapp, C. C., Grist, R., & McNicholas, P. M. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00287-07 · Cited by 30
Ingham, C. J., van den Ende, M., Wever, P. C., & Schneeberger, P. M. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46585-0 · Cited by 30
Matrix-Assisted Laser Desorption Time of Flight Mass Spectrometry
Wolk, D. M., & Clark, A. E. (2018) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2018.05.008 · Cited by 30
Serrano, M. C. L., Morilla, D., Valverde, A., Chávez, M., Espinel‐Ingroff, A., Claro, R. M., Ramírez, M., & Martín‐Mazuelos, E. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5270-5272.2003 · Cited by 28
Arendrup, M. C., Park, S., Brown, S. D., Pfaller, M. A., & Perlin, D. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01373-10 · Cited by 28
Al‐Hatmi, A. M. S., Normand, A., Ranque, S., Piarroux, R., de Hoog, S., Meletiadis, J., & Meis, J. F. G. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01671-16 · Cited by 27
Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.05.007 · Cited by 26
Pfaller, M. A., Diekema, D. J., Procop, G. W., & Wiederhold, N. P. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00658-14 · Cited by 22
Gitman, M., McTaggart, L. R., Spinato, J., Poopalarajah, R., Lister, E., Husain, S., & Kus, J. V. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00254-17 · Cited by 22
Tafin, U. F., Meis, J. F. G. M., & Trampuž, A. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.05.009 · Cited by 21
Cejudo, M. T. G., Gallego, A. G., Lacasa, E. C., Aller, A. I., Romero, A., Pemán, J., Quindós, G., & Martín‐Mazuelos, E. (2010) · Medical Mycology · doi:10.3109/13693780903473343 · Cited by 21
Flow Cytometry Susceptibility Testing for the Antifungal Caspofungin
Mitchell, M. S., Hudspeth, M. K., & Wright, A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2586-2589.2005 · Cited by 20
Sóczó, G., Kardos, G., Varga, I., Kelentey, B., Gesztelyi, R., & Majoros, L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00880-07 · Cited by 18
Vale-Silva, L. A., Pinto, P., Lopes, V., Ramos, H., & Pinto, E. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1390-z · Cited by 17
Idelevich, E. A., Groß, U., Becker, K., & Bader, O. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.01.003 · Cited by 16
Caspofungin Disk Diffusion Breakpoints and Quality Control
Brown, S. D., & Traczewski, M. M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00279-08 · Cited by 15
Mahabeer, Y., Chang, C. C., Naidu, D., Dorasamy, A., Lewin, S. R., Ndung’u, T., Moosa, M.-Y., French, M. A., Mlisana, K. P., & Coovadia, Y. M. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.09.006 · Cited by 15
Pfaller, M. A., Barry, A. L., Billé, J., Brown, S. D., Ellis, D., Meis, J. F. G. M., Rennie, R. P., Rinaldi, M. G., Rogers, T. R., & Traczewski, M. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1716-1718.2004 · Cited by 15
Ozkutuk, A., Ergon, C., Metin, D. Y., Yücesoy, M., & Polat, S. H. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.1.87 · Cited by 13
Chromogenic Medium for Direct Susceptibility Testing of Candida spp. Isolated from Urine
Júnior, A. A. D. V., Menezes, E. A., & Cunha, F. A. (2011) · Mycopathologia · doi:10.1007/s11046-011-9407-9 · Cited by 12
Farina, C., Manso, E., Andreoni, S., Conte, M., Fazii, P., Lombardi, G., Sanna, S., & Russello, G. (2011) · PubMed · Cited by 11
Arendrup, M. C., Verweij, P. E., Mouton, J. W., Lagrou, K., & Meletiadis, J. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky218 · Cited by 11
X-Plate Technology: a new method for detecting fluconazole resistance in Candida species
Chadwick, S. G., Schuyler, J. A., Vermitsky, J., Adelson, M. E., Mordechai, E., & Gygax, S. E. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.054445-0 · Cited by 7
Microcalorimetry Assay for Rapid Detection of Voriconazole Resistance in Aspergillus fumigatus
Tafin, U. F., Meis, J. F. G. M., & Trampuž, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01379-13 · Cited by 7
Cited by
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A., Gabaldón, T., Garcia-Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., Ilkit, M., Lass-Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 292
Antifungal Drugs TDM: Trends and Update
Kably, B., Launay, M., Derobertmasure, A., Lefeuvre, S., Dannaoui, E., & Billaud, E. M. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000952 · Cited by 81
In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa
Maphanga, T. G., Naicker, S. D., Kwenda, S., Muñoz, J. F., van Schalkwyk, E., Wadula, J., Nana, T., Ismail, A., Coetzee, J., Govind, C., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00517-21 · Cited by 78
“We used the Etest method since it generates a much wider range of amphotericin B MIC values than those yielded by BMD testing; this may facilitate distinguishing resistant and susceptible isolates (38).”
MethodJenks, J. D., Gangneux, J.-P., Schwartz, I. S., Alastruey-Izquierdo, A., Lagrou, K., Thompson III, G. R., Lass-Flörl, C., Hoenigl, M., & Investigators, E. C. O. M. M. (. C. (2020) · Journal of Fungi · doi:10.3390/jof6040216 · Cited by 44
Metadata
- Authors
- Berkow, E. L., Lockhart, S. R., & Ostrosky-Zeichner, L.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2020-06-17
- Volume
- 33
- Issue
- 3
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W3023570425
- Cited by
- 368
- References
- 201
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.